Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

Article  CAS  PubMed  Google Scholar 

Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).

Article  CAS  PubMed  Google Scholar 

Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).

Article  CAS  PubMed  Google Scholar 

Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75–82 (2020).

Article  CAS  PubMed  Google Scholar 

Li, R. et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science 370, 82–89 (2020). This study, together with Lawson et al. (2020), showed that morphologically normal urothelium contains extensive driver mutations, notably recurrent KMT2D mutations, and large clonal expansions, establishing that epigenetic regulator loss occurs early during bladder tumour development.

Article  CAS  PubMed  Google Scholar 

Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kapadia, C. D. et al. Clonal dynamics and somatic evolution of haematopoiesis in mouse. Nature 641, 681–689 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller, T. et al. COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc. Natl Acad. Sci. USA 98, 12902–12907 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krogan, N. J. et al. COMPASS, a histone H3 (lysine 4) methyltransferase required for telomeric silencing of gene expression. J. Biol. Chem. 277, 10753–10755 (2002).

Article  CAS  PubMed  Google Scholar 

Shilatifard, A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65–95 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cenik, B. K. & Shilatifard, A. COMPASS and SWI/SNF complexes in development and disease. Nat. Rev. Genet. 22, 38–58 (2021).

Article  CAS  PubMed  Google Scholar 

Wang, L. et al. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nat. Med. 24, 758–769 (2018). This study demonstrated that pharmacological rebalancing of Polycomb and COMPASS activities at enhancers can restore epigenetic equilibrium and suppress tumour growth.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, Z. et al. CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS. Sci. Adv. 8, eadd3339 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, Y. et al. ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers. Nat. Commun. 15, 4883 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel, S. R., Kim, D., Levitan, I. & Dressler, G. R. The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev. Cell 13, 580–592 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, A. H. et al. The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis. EMBO J. 32, 1075–1086 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Smith, E. R. et al. Drosophila UTX is a histone H3 Lys27 demethylase that colocalizes with the elongating form of RNA polymerase II. Mol. Cell Biol. 28, 1041–1046 (2008).

Article  CAS  PubMed  Google Scholar 

Rickels, R. et al. A small UTX stabilization domain of Trr is conserved within mammalian MLL3-4/COMPASS and is sufficient to rescue loss of viability in null animals. Genes Dev. 34, 1493–1502 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao, Z. et al. Somatic mutations of MLL4/COMPASS induce cytoplasmic localization providing molecular insight into cancer prognosis and treatment. Proc. Natl Acad. Sci. USA 120, e2310063120 (2023). This study demonstrated that KMT2D truncating mutations drive aberrant cytoplasmic localization of the KMT2D protein, revealing a previously unrecognized mechanism of epigenetic dysfunction with prognostic and therapeutic implications.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoshii, T. et al. A non-catalytic function of SETD1A regulates cyclin K and the DNA damage response. Cell 172, 1007–1021.e17 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Callen, E. et al. 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 153, 1266–1280 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jowsey, P. A., Doherty, A. J. & Rouse, J. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation. J. Biol. Chem. 279, 55562–55569 (2004).

Article  CAS  PubMed  Google Scholar 

Munoz, I. M., Jowsey, P. A., Toth, R. & Rouse, J. Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage. Nucleic Acids Res. 35, 5312–5322 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, D. et al. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol. Cell Biol. 33, 4745–4754 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herz, H. M. et al. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4. Genes. Dev. 26, 2604–2620 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, S. P. et al. A UTX-MLL4-p300 transcriptional regulatory network coordinately shapes active enhancer landscapes for eliciting transcription. Mol. Cell 67, 308–321.e6 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, C. et al. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition. Proc. Natl Acad. Sci. USA 113, 11871–11876 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, L. & Shilatifard, A. UTX mutations in human cancer. Cancer Cell 35, 168–176 (2019).

Article  CAS  PubMed  PubMed Central